Thomas Sears

Also affiliated with Neurological Surgery, Robert H. Lurie Comprehensive Cancer Center of Northwestern University

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “IDH1 mutant glioma is preferentially sensitive to the HDAC inhibitor panobinostat”.

IDH1 mutant glioma is preferentially sensitive to the HDAC inhibitor panobinostat

Journal of Neuro-Oncology(2021)10.1007/s11060-021-03829-0

N/A

0.669DataRank · unranked

18 citations

Craig Horbinski, Kevin Woolard, Thomas Sears

The epileptic landscape of IDH mutant gliomas.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.2064

N/A

0.104DataRank · unranked

1 citations

Wenxia Wang, Kirsten B. Burdett, Thomas Sears, Rodrigo Javier, Kristen Y. Cotton +15 more

Methylation-induced suppression of YAP/TAZ confers sensitivity to HDAC inhibitors in high-grade IDH mutant gliomas

JCI Insight(2025)10.1172/jci.insight.195385

N/A

0.104DataRank · unranked

1 citations

Matthew McCord, Wenxia Wang, Alicia Steffens, Kathleen McCortney, Rahul K. Chaliparambil +3 more

Dynamic release of extracellular particles after opening of the blood-brain barrier predicts glioblastoma susceptibility to paclitaxel

Nature Communications(2025)10.1038/s41467-025-65681-4

N/A

0DataRank · unranked

7 citations

Abha Kumari, Yoon‐Tae Kang, Andrew Gould, Karl J. Habashy, Mateo Gomez +25 more

Postoperative risk of IDH mutant glioma–associated seizures and their potential management with IDH mutant inhibitors

Journal of Clinical Investigation(2023)10.1172/jci168035

N/A

0DataRank · unranked

50 citations

Wenxia Wang, Thomas Sears, Kirsten B. Burdett, Rodrigo Javier, Kristen Y. Cotton +19 more

Repurposing FDA approved drugs inhibiting mitochondrial function for targeting glioma-stem like cells

Biomedicine & Pharmacotherapy(2020)10.1016/j.biopha.2020.111058

N/A

0DataRank · unranked

34 citations

Thomas Sears, Gino Cortopassi, Kevin Woolard, James M. Angelastro, Sandipan Datta

The novel DNA cross-linking agent KL-50 is active against patient-derived models of new and recurrent post-temozolomide mismatch repair-deficient glioblastoma

Neuro-Oncology(2024)10.1093/neuonc/noae257

N/A

0DataRank · unranked

9 citations

Thomas Sears, Wenxia Wang, Rahul K. Chaliparambil, Shejuan An, Jann N. Sarkaria +6 more